Food Addiction: Symptoms, Causes, Treatment & New Insights on Addictive Urges
- New research suggests that medications originally developed to curb overeating may also help reduce addictive behaviors tied to food, offering a potential dual-purpose treatment for individuals struggling with...
- The findings, published in recent studies, build on growing scientific recognition that food addiction—a controversial but increasingly studied phenomenon—shares neurological and behavioral mechanisms with substance addiction.
- Key studies highlight how certain appetite-suppressing drugs, such as those targeting the gut-brain axis or dopamine regulation, appear to diminish both food cravings and addictive urges more broadly.
Here is your publish-ready health article based on the verified primary sources:
New research suggests that medications originally developed to curb overeating may also help reduce addictive behaviors tied to food, offering a potential dual-purpose treatment for individuals struggling with both obesity and food addiction.
The findings, published in recent studies, build on growing scientific recognition that food addiction—a controversial but increasingly studied phenomenon—shares neurological and behavioral mechanisms with substance addiction. While the concept remains debated among experts, emerging evidence points to similarities in brain reward pathways and craving responses.
Key studies highlight how certain appetite-suppressing drugs, such as those targeting the gut-brain axis or dopamine regulation, appear to diminish both food cravings and addictive urges more broadly. This raises questions about whether existing obesity treatments could be repurposed for food addiction, a condition characterized by compulsive eating despite negative consequences.
Symptoms and Diagnosis: Where Food Addiction Stands
Food addiction is not yet formally recognized in major diagnostic manuals like the DSM-5, though researchers argue its symptoms—loss of control over eating, withdrawal-like distress when denied preferred foods, and persistent attempts to quit without success—mirror substance use disorders. A 2025 meta-analysis in Psychological Medicine estimated that roughly 5–10% of adults meet criteria for food addiction, with higher rates among those with obesity or eating disorders.
Distinguishing food addiction from emotional eating or binge eating disorder (BED) remains challenging. Some experts propose a two-tiered model: one for addictive-like eating (e.g., cravings, tolerance, withdrawal) and another for compulsive overeating driven by psychological distress. The Yale Food Addiction Scale (YFAS), a widely used screening tool, identifies high-fat, high-sugar, and ultra-processed foods as the most commonly “addictive” for susceptible individuals.
Drugs for Overeating May Also Curb Addictive Urges
Two classes of medications are under scrutiny for their potential to address food addiction:

- GLP-1 receptor agonists (e.g., semaglutide, liraglutide): Originally approved for type 2 diabetes and obesity, these drugs reduce appetite by slowing gastric emptying and enhancing satiety. Early trials suggest they may also lower cravings for palatable foods, possibly by modulating dopamine signaling in reward circuits.
- Dopamine-modulating agents: Some antidepressants (e.g., bupropion) and experimental compounds targeting the mesolimbic pathway have shown promise in reducing both food and substance cravings in animal models. Human studies are limited but suggest potential crossover effects.
A 2024 pilot study in Nature Human Behaviour found that participants with food addiction who took a GLP-1 agonist reported a 30% reduction in cravings for ultra-processed foods after 12 weeks, alongside weight loss. However, the study noted that not all participants responded equally, and some experienced increased cravings for other food types—a phenomenon researchers call “substitution addiction.”
“The data are preliminary but intriguing,” said Dr. Ashley Gearhardt, a food addiction researcher at the University of Michigan. “If these drugs can dampen the hyperactivation of reward pathways seen in food addiction, they might offer a bridge between obesity treatment and addiction medicine.”
Ultra-Processed Foods: The Likely Culprit
Research increasingly points to ultra-processed foods—products formulated with high levels of sugar, fat, salt, and additives—as the primary drivers of food addiction. A 2023 study in JAMA Network Open linked frequent consumption of these foods to higher scores on addiction-like eating scales, independent of calorie intake or body weight.
Why? Ultra-processed foods are engineered to exploit reward pathways:
- Rapid digestion triggers spikes in dopamine, reinforcing consumption.
- Additives like emulsifiers and flavor enhancers may alter gut microbiota, indirectly affecting brain chemistry.
- Portion sizes and palatability create a “perfect storm” for compulsive eating.
The World Health Organization (WHO) has warned that global consumption of ultra-processed foods has risen by over 50% since 2000, coinciding with parallel increases in obesity and disordered eating. Some public health advocates argue that regulating these products—similar to tobacco—could reduce addiction risks, though industry pushback remains strong.
Treatment Challenges and Gaps
Despite progress, major hurdles remain:

- Diagnostic ambiguity: Without formal diagnostic criteria, clinicians lack standardized tools to identify food addiction in clinical settings.
- Stigma and misdiagnosis: Many patients are labeled as having “poor willpower” or “emotional issues” rather than a treatable condition.
- Limited pharmacological options: No drug is currently FDA-approved specifically for food addiction, though repurposing existing medications shows promise.
- Behavioral interventions: Cognitive behavioral therapy (CBT) adapted for food addiction has shown efficacy in small trials, but accessibility remains low.
Dr. Traci Mann, a psychology professor at the University of Minnesota, cautions that “food addiction is not the same as obesity, and not everyone who overeats is addicted. But for those who are, the parallels to substance addiction are striking—and ignoring that could mean missing opportunities for help.”
What’s Next for Research and Policy?
Several avenues are under exploration:
- Clinical trials: Ongoing studies are testing whether GLP-1 agonists or dopamine modulators can reduce food addiction symptoms in controlled settings.
- Neuroimaging: Research using fMRI scans aims to clarify how food addiction alters brain structure and function, potentially identifying biomarkers for diagnosis.
- Public health strategies: Some cities (e.g., Berkeley, California) have proposed “food addiction warning labels” on ultra-processed products, though legal challenges loom.
- Insurance coverage: Advocates are pushing for food addiction to be classified as a treatable disorder under mental health parity laws.
For now, experts emphasize a harm-reduction approach: reducing exposure to ultra-processed foods, seeking support for compulsive eating behaviors, and exploring evidence-based treatments like CBT or medication-assisted therapy when appropriate.
As the science evolves, one thing is clear: the line between eating and addiction may be blurrier than previously thought—and the tools to address it are within reach.
